Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Prometryn SCHEMBL7657627 | 0.86 | MAPK1 (0.56) | MAPK1TSHRSMN1; SMN2HSD17B10GAA | |
| Prometryn SCHEMBL7622 | 0.86 | MAPK1 (0.56) | MAPK1TSHRSMN1; SMN2HSD17B10GAA | |
| Prometryn SCHEMBL9534325 | 0.84 | MAPK1 (0.43) | MAPK1HSP90AB1TSHRSMN1; SMN2HSD17B10 | |
| Prometryn SCHEMBL20723889 | 0.84 | GAA (0.58) | MAPK1TSHRSMN1; SMN2HSD17B10GAA | |
| SCHEMBL8059674 | 0.81 | GAA (0.58) | MAPK1GAATDP1KMT2AALDH1A1 | |
| SCHEMBL8059668 | 0.81 | GAA (0.52) | MAPK1GAATDP1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11478940 | 0.79 | GAA (0.50) | MAPK1GAATDP1KMT2AALDH1A1 | |
| SCHEMBL24059309 | 0.78 | MAPK1 (0.50) | MAPK1HSP90AB1TSHRSMN1; SMN2HSD17B10 | |
| SCHEMBL29435432 | 0.78 | MAPK1 (0.50) | MAPK1TSHRSMN1; SMN2HSD17B10GAA | |
| SCHEMBL8827500 | 0.78 | MAPK1 (0.50) | MAPK1TSHRSMN1; SMN2HSD17B10GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110218105-A1 | PRE-PLANT OR PRE-EMERGENT HERBICIDE COMPOSITIONS | WALKER LARRY | 2011-09-08 | — | — | US | claimed |
| CN-101578046-A | herbicidal composition | ISAGRO SPA (IT) | 2009-11-11 | — | — | CN | claimed |
| EP-1998616-A1 | NEW SYNERGISTIC HERBICIDAL COMPOSITIONS | Isagro Ricerca S.r.l. (IT) | 2008-12-10 | — | — | EP | claimed |
| WO-2007101587-A1 | NEW SYNERGISTIC HERBICIDAL COMPOSITIONS | ISAGRO RICERCA S.R.L. (IT) | 2007-09-13 | — | — | WO | claimed |
| EP-1429612-A1 | HERBICIDES CONTAINING SUBSTITUTED THIEN-3-YL-SULFONYLAMINO(THIO)CARBONYL-TRIAZOLIN(THI)ONE | Bayer CropScience AG (DE) | 2004-06-23 | — | — | EP | claimed |
| WO-2003026426-A1 | HERBICIDES CONTAINING SUBSTITUTED THIEN-3-YL-SULFONYLAMINO(THIO)CARBONYL-TRIAZOLIN(THI)ONE | BAYER CROPSCIENCE AG (DE) | 2003-04-03 | — | — | WO | claimed |
| US-20240226160-A9 | ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131072-A1 | ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2024-04-25 | — | — | US | disclosed |
| EP-4291571-A2 | ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN | Seattle Children's Hospital d/b/a Seattle Children's Research Institute (US) | 2023-12-20 | — | — | EP | disclosed |
| WO-2023220440-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-16 | — | — | WO | disclosed |
| US-20230322925-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | SEATTLE CHILDREN’S HOSPITAL DBA SEATTLE CHILDREN’S RES INSTITUTE (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230203484-A1 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | WAVE LIFE SCIENCES LTD. (SG) | 2023-06-29 | — | — | US | disclosed |
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-06-29 | — | — | US | disclosed |
| WO-2003020035-A2 | SELECTIVE HERBICIDE COMPRISING A TETRAZOLINONE DERIVATIVE | BAYER CROPSCIENCE AG (DE) | 2003-03-13 | — | — | WO | disclosed |
| EP-0787429-B1 | Application of a composition for regulating plant growth | NIHON NOHYAKU CO LTD (JP) | 2001-12-12 | — | — | EP | disclosed |
| US-20010039321-A1 | Siloxane-containing oil compositions with good spreading properties | EVONIK GOLDSCHMIDT GMBH (DE) | 2001-11-08 | — | — | US | disclosed |
| EP-1136515-A2 | Siloxane-containing oil compositions with good spreading properties | Goldschmidt AG (DE) | 2001-09-26 | — | — | EP | disclosed |
| CN-1309533-A | Herbicidal composition | AVENTIS CORPSCIENCE GMBH (DE) | 2001-08-22 | — | — | CN | disclosed |
| US-6117818-A | COMPRISES AS AN ACTIVE INGREDIENT AT LEAST ONE 3-SUBSTITUTED PHENYLPYRAZOLE DERIVATIVE WHICH ACTS AS A DESICCANT OR DEFOLIANT FOR ROOT VEGETABLES, FIBER CROPS, OIL CROPS | NIHON NOHYAKU CO., LTD. (JP) | 2000-09-12 | — | — | US | disclosed |
| EP-0787429-A2 | A composition for regulating plant growth and a method for application thereof | NIHON NOHYAKU CO., LTD. (JP) | 1997-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203087-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | RNGTT, NSUN2, ALKBH1 | MAPK1 3843/4885HSP90AB1 4862/4885TSHR 4131/4885 |
| US-20110218105-A1 | PRE-PLANT OR PRE-EMERGENT HERBICIDE COMPOSITIONS | TPH1, DDT, MTX1 | MAPK1 4143/4885HSP90AB1 1991/4885TSHR 3906/4885 |
| US-20230322925-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | PHOSPHO1, LCAT, CD47 | MAPK1 2931/4885HSP90AB1 2958/4885TSHR 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.